XML 37 R21.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 10 - Income Taxes
12 Months Ended
Dec. 28, 2024
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

10.

Income Taxes

 

Total income tax expense (benefit) was allocated as follows:

 

(in thousands)

 

2024

   

2023

   

2022

 

Income from operations

  $ 4,872     $ 17,660     $ 29,868  

Other comprehensive income

    396       (984 )     755  

Total

  $ 5,268     $ 16,676     $ 30,623  

 

Significant components of the provision (benefit) for income taxes are as follows:

 

(in thousands)

 

2024

   

2023

   

2022

 

Current:

                       

U.S. Federal

  $ 717     $ 694     $ 1,609  

U.S. State

    36       86       456  

Foreign

    7,841       21,654       31,307  

Total current

    8,594       22,434       33,372  

Deferred:

                       

U.S. Federal

    (13 )     61       (9 )

Foreign

    (3,709 )     (4,835 )     (3,495 )

Total deferred

    (3,722 )     (4,774 )     (3,504 )
    $ 4,872     $ 17,660     $ 29,868  

 

Income (loss) before income taxes consisted of the following:

 

(in thousands)

 

2024

   

2023

   

2022

 

U.S.

  $ (85,450 )   $ (37,799 )   $ 9,180  

Foreign

    20,504       83,615       117,535  

Total

  $ (64,946 )   $ 45,816     $ 126,715  

 

 

Deferred tax effects

 

Except for working capital requirements in certain foreign jurisdictions, we provide for substantially all taxes, including withholding and other residual taxes, related to unremitted earnings of our foreign subsidiaries.

 

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting and tax purposes. Significant components of our deferred tax assets and liabilities were as follows:

 

(in thousands)

 

2024

   

2023

 

Deferred tax assets:

               

Inventory, receivable and warranty reserves

  $ 11,034     $ 10,931  

Net operating loss carryforwards

    39,572       36,602  

Tax credit carryforwards

    35,788       34,637  

Capitalized R&D

    35,348       30,485  

Accrued employee benefits

    3,742       3,348  

Stock-based compensation

    4,511       3,227  

Lease liabilities

    2,544       3,222  

Uniform capitalization

    2,553       1,564  

Other

    3,064       -  

Gross deferred tax assets

    138,156       124,016  

Less valuation allowance

    (114,517 )     (99,888 )

Total deferred tax assets

    23,639       24,128  

Deferred tax liabilities:

               

Intangible assets and other acquisition basis differences

    25,848       34,076  

Operating lease right-of-use assets

    2,226       2,854  

Unremitted earnings of foreign subsidiaries

    4,898       4,106  

Other

    4,986       50  

Total deferred tax liabilities

    37,958       41,086  

Net deferred tax liabilities

  $ (14,319 )   $ (16,958 )

 

The components of total net deferred tax assets (liabilities), net of valuation allowances, as shown in our consolidated balance sheets are as follows:

 

(in thousands)

 

2024

   

2023

 

Other assets (long-term)

  $ 5,083     $ 6,196  

Long-term deferred income tax liabilities

    (19,402 )     (23,154 )

Net deferred tax liabilities

  $ (14,319 )   $ (16,958 )

 

Companies are required to assess whether a valuation allowance should be recorded against their deferred tax assets (“DTAs”) based on the consideration of all available evidence, using a “more likely than not” realization standard. The four sources of taxable income that must be considered in determining whether DTAs will be realized are, (1) future reversals of existing taxable temporary differences (i.e. offset of gross deferred tax assets against gross deferred tax liabilities); (2) taxable income in prior carryback years, if carryback is permitted under the tax law; (3) tax planning strategies and (4) future taxable income exclusive of reversing temporary differences and carryforwards.

 

In assessing whether a valuation allowance is required, significant weight is to be given to evidence that can be objectively verified. We have evaluated our DTAs each reporting period, including an assessment of taxable income in prior carryback years, future reversals of existing taxable temporary differences, future taxable income exclusive of reversing temporary differences and carryforwards, and prudent and feasible tax planning strategies that we would be willing to undertake to prevent a deferred tax asset from otherwise expiring.

 

The assessment regarding whether a valuation allowance is required or whether a change in judgement regarding the valuation allowance has occurred also considers all available positive and negative evidence, including but not limited to:

 

 

Nature, frequency, and severity of cumulative losses in recent years

 

 

Duration of statutory carryforward and carryback periods

 

 

Statutory limitations against utilization of tax attribute carryforwards against taxable income

 

 

Historical experience with tax attributes expiring unused

 

 

Near- and medium-term financial outlook

 

The weight given to the positive and negative evidence is commensurate with the extent to which the evidence may be objectively verified. Accordingly, it is generally difficult to conclude a valuation allowance is not required when there is significant objective and verifiable negative evidence, such as cumulative losses in recent years. We use the actual results for the last two years and current year results as the primary measure of cumulative losses in recent years.

 

The evaluation of deferred tax assets requires judgment in assessing the likely future tax consequences of events recognized in the financial statements or tax returns and future profitability. The recognition of deferred tax assets represents our best estimate of those future events. Changes in the current estimates, due to unanticipated events or otherwise, could have a material effect on our results of operations and financial condition.

 

In certain tax jurisdictions, our analysis indicates that it has cumulative losses in recent years. This is considered significant negative evidence, which is objective and veritable and, therefore, difficult to overcome. However, the cumulative loss position is not solely determinative and, accordingly, we consider all other available positive and negative evidence in this analysis. Based on the evidence available, including a lack of sustainable earnings and history of expiring unused net operating losses and tax credits, we continue to maintain the judgement that a previously recorded valuation allowance against substantially all net deferred tax assets in the United States is required. If a change in judgement regarding this valuation allowance were to occur in the future, we will record a potentially material deferred tax benefit, which could result in a favorable impact on the effective tax rate in that period.

 

Our valuation allowance on our DTAs at December 28, 2024, and December 30, 2023, was approximately $114.5 million and $99.9 million, respectively. The remaining gross DTAs for which a valuation allowance was not recorded are realizable primarily through future reversals of existing taxable temporary differences and to a lesser extent future taxable income in certain jurisdictions exclusive of reversing temporary differences and carryforwards.

 

The reconciliation of income tax computed at the U.S. federal statutory tax rate to the provision for income taxes is as follows:

 

(in thousands)

 

2024

   

2023

   

2022

 

Tax provision at U.S. 21% statutory rate

  $ (13,638 )   $ 9,470     $ 26,610  

State income taxes, net of federal tax benefit

    (2,126 )     (633 )     (1,535 )

Accruals, adjustments and releases from statute expirations

    (2,372 )     579       348  

Federal R&D credits

    (1,103 )     (1,360 )     (1,679 )

Stock-based compensation

    502       (1,504 )     (572 )

Excess executive compensation

    715       1,375       946  

Change in valuation allowance

    14,844       10,654       13,307  

GILTI, net of foreign tax credits

    2,613       1,735       3,458  

Foreign rate differential

    146       2,093       (6,131 )

Withholding and other foreign taxes, net of foreign tax credit

    1,206       254       (3,819 )

Other, net

    4,085       (5,003 )     (1,065 )
    $ 4,872     $ 17,660     $ 29,868  

 

An accounting policy may be selected to either (i) treat taxes due on future U.S. inclusions in taxable income related to global intangible low-taxed income (“GILTI”) as a current-period expense when incurred or (ii) factor such amounts into a company’s measurement of its deferred taxes. We have elected to account for GILTI as a period cost.

 

At December 28, 2024, we had federal, state and foreign net operating loss carryforwards of approximately $140.3 million, $127.8 million and $1.8 million, respectively, that expire in various tax years beginning in 2025 through 2043 or have no expiration date. We also have federal and state tax credit carryforwards at December 28, 2024 of approximately $3.0 million and $35.4 million, respectively, certain of which expire in various tax years beginning in 2025 through 2043, or have no expiration date. The federal and state loss and credit carryforwards are subject to annual limitations under Sections 382 and 383 of the Internal Revenue Code and applicable state tax laws. We analyzed and determined that there were no ownership changes during the three-year period ending December 28, 2024. We will continue to assess the realizability of these carryforwards in subsequent periods. Future changes in the ownership of Cohu could further limit the utilization of these carryforwards.

 

We have certain tax holidays with respect to our operations in Malaysia and the Philippines. These holidays require compliance with certain conditions and expire at various dates through 2038. The impact of these holidays was an increase in net income of approximately $1.0 million or $0.02 per share in 2024, $3.8 million or $0.08 per share in fiscal 2023 and $4.5 million, or $0.09 per share in fiscal 2022.

 

A reconciliation of our gross unrecognized tax benefits, excluding accrued interest and penalties, is as follows:

 

(in thousands)

 

2024

   

2023

   

2022

 

Balance at beginning of year

  $ 35,900     $ 33,368     $ 33,391  

Additions for tax positions of current year

    858       899       910  

Additions/(Reductions) for tax positions of prior years

    (788 )     1,802       (428 )

Reductions due to lapse of the statute of limitations

    (2,089 )     (295 )     (354 )

Foreign exchange rate impact

    (116 )     126       (151 )

Balance at end of year

  $ 33,765     $ 35,900     $ 33,368  

 

If the unrecognized tax benefits at December 28, 2024 are ultimately recognized, excluding the impact of U.S. tax benefits netted against deferred taxes that are subject to a valuation allowance, approximately $5.2 million ($7.5 million at December 30, 2023 and $5.8 million at December 31, 2022) would result in a reduction in our income tax expense and effective tax rate. It is reasonably possible that unrecognized tax benefits related to transfer pricing and foreign withholding tax will decrease by up to $0.2 million within the next 12 months.

 

We recognize interest and penalties related to unrecognized tax benefits in income tax expense. Cohu had approximately $0.5 million and $0.7 million accrued for the payment of interest and penalties at December 28, 2024, and December 30, 2023, respectively. Interest expense, net of accrued interest reversed, was $(0.2) million in 2024 and $(0.1) million in 2023 and 2022.

 

Our U.S. federal income tax returns for fiscal 2008 and for years after fiscal 2020 remain open to examination, subject to the statute of limitations. Our U.S. state income tax returns for years after fiscal 2019 remain open to examination, subject to the statute of limitations. Net operating loss and credit carryforwards arising prior to these years are also open to examination if and when utilized. The statute of limitations for the assessment and collection of income taxes related to our foreign tax returns varies by country. In the foreign countries where we have significant operations these time periods generally range from four to ten years after the year for which the tax return is due or the tax is assessed.

 

We conduct business globally and as a result, Cohu or one or more of its subsidiaries files income tax returns in the U.S. and various state and foreign jurisdictions. In the normal course of business, we are subject to examinations by taxing authorities throughout the world and are currently under examination in Germany, Singapore, Philippines and the United States. We believe our financial statement accruals for income taxes are appropriate.

 

Tax positions have been reflected in the consolidated financial statements in accordance ASC Topic 740, Income Taxes, (“ASC 740”), Income Taxes. Such tax positions are, based solely on their technical merits, more likely than not to be sustained upon examination by taxing authorities and reflect the largest amount of benefit, determined on a cumulative probability basis, that is more likely than not to be realized upon settlement with the applicable taxing authority with full knowledge of all relevant information. We have both intent and ability to initiate a claim pursuant to the competent authority (e.g., Mutual Agreement Procedure) for reasonable and prudent situations such as, for example, when the resulting tax benefit exceeds the costs involved to obtain such tax benefit, and the success of prevailing upon pursuing the competent authority is more likely than not achievable.